{
    "clinical_study": {
        "@rank": "11808", 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the effectiveness of taking didanosine (ddI) once a\n      day plus stavudine (d4T) twice a day with taking ddI twice a day plus d4T twice a day. This\n      study also examines the safety of giving ddI with d4T in the short-term."
        }, 
        "brief_title": "A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients", 
        "completion_date": {
            "#text": "February 2004", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients are randomized to receive ddI given either qd or bid in combination with d4T given\n      bid (no doses specified)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  Documented HIV infection.\n\n          -  CD4 cell count of at least 100 cells/mm3.\n\n          -  Plasma HIV RNA count of 10,000 copies/ml or more within 14 days prior to study entry.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions and symptoms are excluded:\n\n          -  Presence of a newly diagnosed AIDS-defining opportunistic infection requiring acute\n             therapy at the time of enrollment.\n\n          -  Bilateral peripheral neuropathy or signs and symptoms of bilateral peripheral\n             neuropathy greater than or equal to Grade 2 at the time of screening.\n\n          -  Inability to tolerate oral medication.\n\n          -  Any other clinical condition that would preclude compliance with dosing requirements.\n\n        Patients with the following prior conditions are excluded:\n\n          -  History of acute or chronic pancreatitis.\n\n          -  Intractable diarrhea (6 or more loose stools/day for more than 7 consecutive days)\n             within 30 days prior to study entry.\n\n          -  Proven or suspected acute hepatitis within 30 days prior to study entry.\n\n             1. Potent neurotoxic drugs, such as vincristine and thalidomide.\n\n          -  Other anti-HIV therapy.\n\n             1. Prophylaxis for pneumocystis carinii pneumonia (PCP) is strongly recommended for\n             patients with CD4 cell counts less than or equal to 200/mm3 or who have had a prior\n             episode of PCP.\n\n          -  Immunizations recommended by ACIP for routine practice.\n\n          -  Erythropoietin and G-CSF are allowed if myelosuppression emerges on study.\n\n             1. Any antiretroviral therapy.\n\n          -  Agents with significant systemic myelosuppressive, neurotoxic, pancreatotoxic,\n             hepatotoxic, or cytotoxic potential within 3 months of study entry.\n\n             1. Any prior antiretroviral therapy.\n\n          -  Agents with significant systemic myelosuppressive, neurotoxic, pancreatotoxic,\n             hepatotoxic, or cytotoxic potential within 3 months of study entry.\n\n        Active alcohol or substance abuse that would prevent adequate compliance or would increase\n        the risk of pancreatitis."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002207", 
            "org_study_id": "039D", 
            "secondary_id": "AI454-143"
        }, 
        "intervention": [
            {
                "intervention_name": "Stavudine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Didanosine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Didanosine", 
                "Stavudine", 
                "Reverse Transcriptase Inhibitors"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Didanosine", 
            "Drug Therapy, Combination", 
            "Stavudine", 
            "Reverse Transcriptase Inhibitors"
        ], 
        "lastchanged_date": "April 13, 2011", 
        "link": [
            {
                "description": "BMS Clinical Trials Disclosure", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35203"
                    }, 
                    "name": "Clinsites / Sorra Research Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tarzana", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91356"
                    }, 
                    "name": "Shared Med Research Foundation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Indiana Univ School of Medicine / Dept of Infect Dis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ypsilanti", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48197"
                    }, 
                    "name": "Medicine Faculty Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07103"
                    }, 
                    "name": "New Jersey Community Research Initiative"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Somerville", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08876"
                    }, 
                    "name": "ID Care Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97219"
                    }, 
                    "name": "Fanno Creek Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15213"
                    }, 
                    "name": "Anderson Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75235"
                    }, 
                    "name": "Univ of Texas Southwestern Med Ctr of Dallas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Galveston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "775550835"
                    }, 
                    "name": "Univ of Texas Med Branch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77006"
                    }, 
                    "name": "Houston Clinical Research Network"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hampton", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23666"
                    }, 
                    "name": "Hampton Roads Med Specialists"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23220"
                    }, 
                    "name": "Dr Iraj Mirshahi"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized, Double-Blind Study of the Antiviral Activity of Once-Daily and Twice-Daily Dosing of Didanosine in Combination With Twice-Daily Dosing of Stavudine in HIV-Infected Subjects", 
        "overall_official": {
            "affiliation": ".", 
            "last_name": ". .", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2004", 
            "@type": "Actual"
        }, 
        "reference": {
            "PMID": "10449279", 
            "citation": "Mobley JE, Pollard RB, Schrader S, Adler MH, Kelleher T, McLaren C. Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine. AI454-143 Team. AIDS. 1999 Jul 30;13(11):F87-93."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002207"
        }, 
        "source": "Bristol-Myers Squibb", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2004", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2011"
    }, 
    "geocoordinates": {
        "Anderson Clinical Research": "40.441 -79.996", 
        "Clinsites / Sorra Research Ctr": "33.521 -86.802", 
        "Dr Iraj Mirshahi": "37.541 -77.436", 
        "Fanno Creek Clinic": "45.523 -122.676", 
        "Hampton Roads Med Specialists": "37.03 -76.345", 
        "Houston Clinical Research Network": "29.76 -95.369", 
        "ID Care Inc": "40.574 -74.61", 
        "Indiana Univ School of Medicine / Dept of Infect Dis": "39.769 -86.158", 
        "Medicine Faculty Associates": "42.241 -83.613", 
        "New Jersey Community Research Initiative": "40.736 -74.172", 
        "Shared Med Research Foundation": "34.149 -118.551", 
        "Univ of Texas Med Branch": "29.301 -94.798", 
        "Univ of Texas Southwestern Med Ctr of Dallas": "32.803 -96.77"
    }
}